Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Assets Average: 2009-2024

Historic Assets Average for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $78.7 million.

  • Cumberland Pharmaceuticals' Assets Average fell 13.82% to $66.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.9 million, marking a year-over-year decrease of 13.82%. This contributed to the annual value of $78.7 million for FY2024, which is 9.93% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Assets Average stood at $78.7 million for FY2024, which was down 9.93% from $87.4 million recorded in FY2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Assets Average peaked at $100.5 million during FY2020, and registered a low of $78.7 million during FY2024.
  • In the last 3 years, Cumberland Pharmaceuticals' Assets Average had a median value of $87.4 million in 2023 and averaged $84.9 million.
  • Data for Cumberland Pharmaceuticals' Assets Average shows a maximum YoY declined of 9.99% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Assets Average stood at $100.5 million in 2020, then declined by 9.99% to $90.5 million in 2021, then decreased by 1.96% to $88.7 million in 2022, then declined by 1.51% to $87.4 million in 2023, then fell by 9.93% to $78.7 million in 2024.